COMPASS THERAPEUTICS INC's ticker is CMPX and the CUSIP is 20454B104. A total of 35 filers reported holding COMPASS THERAPEUTICS INC in Q2 2022. The put-call ratio across all filers is - and the average weighting 1.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $44,054,815 | -38.1% | 22,362,850 | 0.0% | 0.94% | -27.4% |
| Q2 2023 | $71,113,863 | -2.8% | 22,362,850 | 0.0% | 1.29% | -10.2% |
| Q1 2023 | $73,126,520 | -35.0% | 22,362,850 | 0.0% | 1.44% | -33.3% |
| Q4 2022 | $112,485,136 | +124.7% | 22,362,850 | +1.8% | 2.15% | +131.6% |
| Q3 2022 | $50,071,000 | -14.0% | 21,960,850 | 0.0% | 0.93% | -11.9% |
| Q2 2022 | $58,196,000 | +96.3% | 21,960,850 | +1.5% | 1.06% | +119.3% |
| Q1 2022 | $29,651,000 | -56.8% | 21,642,975 | 0.0% | 0.48% | -45.5% |
| Q4 2021 | $68,608,000 | – | 21,642,975 | – | 0.88% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Consonance Capital Management LP | 3,500,000 | $11,165,000 | 7.28% |
| Foresite Capital Management V, LLC | 4,400,000 | $13,948,000 | 3.43% |
| CHI Advisors LLC | 3,023,692 | $9,585,000 | 3.18% |
| Foresite Capital Opportunity Management V, LLC | 1,100,000 | $3,487,000 | 2.34% |
| Monashee Investment Management LLC | 2,000,000 | $6,340,000 | 1.57% |
| Orbimed Advisors | 21,642,975 | $68,608,000 | 0.88% |
| Rock Springs Capital Management LP | 5,328,088 | $16,890,000 | 0.39% |
| Vivo Capital, LLC | 2,000,000 | $6,340,000 | 0.38% |
| SPHERA FUNDS MANAGEMENT LTD. | 700,000 | $2,219,000 | 0.24% |
| DAFNA Capital Management LLC | 196,091 | $622,000 | 0.16% |